Immune Reconstitution Associated with CMV Reactivation after Discontinuation of Letermovir Prophylaxis - a Prospective Study (TCT-ASTCT-CIBMTR 2026) - Jan 8, 2026 - Abstract #761; 568; Pres time: Feb 5, 2026; 06:30 PM - 08:00 PM; Location: Hall AB (Salt Palace Convention Center); "In contrast, the decline of activated T cells provides additional evidence for the CMV-derived suppression of the immune system that could increase the risk of secondary infections. - late CMV infection incidence - terminally differentiated T EM cells as a candidate biomarker to predict CMV reactivations - impact of CMV reactivations on the immune system"
Clinical • Cytomegalovirus Infection • Infectious Disease • CCR7 • CD8
|
|
Agnieszka Piekarska, MD PhD 1; Patryk Sobieralski, MD PhD 1; Anna Lojko--Dankowska, MD PhD 2; Krzysztof Lewandowski, MD PhD 3; Patrycja Goczewska, PhD 4; Alicja Sadowska-Klasa, MD PhD 1; Jan Maciej Zaucha, Prof. 1; Lidia Gil, Prof. 5
|